PEIRETTI, ENRICO
 Distribuzione geografica
Continente #
EU - Europa 96.052
NA - Nord America 4.315
AS - Asia 727
AF - Africa 23
OC - Oceania 5
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 101.127
Nazione #
IT - Italia 94.743
US - Stati Uniti d'America 4.290
CN - Cina 508
SE - Svezia 430
UA - Ucraina 332
DE - Germania 202
SG - Singapore 135
FI - Finlandia 117
GB - Regno Unito 108
VN - Vietnam 28
IN - India 26
CA - Canada 21
CH - Svizzera 17
FR - Francia 17
BE - Belgio 16
EG - Egitto 15
NL - Olanda 15
IR - Iran 12
RU - Federazione Russa 10
ES - Italia 7
IE - Irlanda 7
GR - Grecia 6
MU - Mauritius 6
CZ - Repubblica Ceca 5
HK - Hong Kong 4
HU - Ungheria 4
AU - Australia 3
PL - Polonia 3
PT - Portogallo 3
AT - Austria 2
BR - Brasile 2
IL - Israele 2
JP - Giappone 2
MX - Messico 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
RO - Romania 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
AP - ???statistics.table.value.countryCode.AP??? 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CU - Cuba 1
DK - Danimarca 1
EU - Europa 1
HR - Croazia 1
IQ - Iraq 1
KR - Corea 1
KW - Kuwait 1
LI - Liechtenstein 1
MD - Moldavia 1
PE - Perù 1
PR - Porto Rico 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 101.127
Città #
Cagliari 94.428
Fairfield 602
Woodbridge 437
Chandler 399
Nyköping 358
Houston 333
Ashburn 330
Wilmington 265
Seattle 256
Ann Arbor 237
Cambridge 226
Jacksonville 178
Dearborn 115
Shanghai 98
Beijing 89
Boardman 79
Helsinki 67
Boston 65
Singapore 60
Nanjing 59
New York 47
San Diego 36
Rome 30
Dong Ket 26
Milan 25
Redwood City 25
Sassari 23
Selargius 22
Shenyang 21
Hebei 19
Nanchang 19
Guangzhou 18
London 17
Jiaxing 16
Toronto 16
Yverdon 16
Changsha 13
Brussels 12
Mountain View 12
Ardabil 11
Norwalk 11
San Mateo 11
Augusta 10
Los Angeles 10
Orange 10
Slough 10
Zhengzhou 10
Cairo 9
Hefei 9
Auburn Hills 8
Monmouth Junction 8
Tianjin 8
Verona 8
Wuhan 8
Jinan 7
Ningbo 7
Torino 7
Ahmedabad 6
Chicago 6
Detroit 6
Jinhua 6
Kunming 6
Leawood 6
Naples 6
Amsterdam 5
Dublin 5
Falls Church 5
Manchester 5
Mumbai 5
Washington 5
Borås 4
Cologne 4
Groningen 4
Heze 4
Madrid 4
Phoenix 4
Athens 3
Darlington 3
Edinburgh 3
Hangzhou 3
Islington 3
Kilburn 3
Kurukshetra 3
Millbury 3
Olomouc 3
Pune 3
Shenzhen 3
Taizhou 3
Valmontone 3
Ypsilanti 3
Zibo 3
Belgrade 2
Bengaluru 2
Catania 2
Central 2
Chengdu 2
Culiacán 2
Frankfurt am Main 2
Fuzhou 2
Gava 2
Totale 99.415
Nome #
null 3.998
Glucose-6-phosphate-dehydrogenase deficiency as a risk factor for pterygium 2.999
null 2.985
Abnormal lipid accumulation and cluster formation of naive peripheral blood mononuclear cells: a useful tool for early detection of central nervous system damage in elderly 2.633
Comparison of inverted flap and subretinal aspiration technique in full-thickness macular hole surgery: a randomized controlled study 1.834
Fibroblasts isolated from human pterygia exhibit altered lipid metabolism characteristics 1.812
OCT angiography characteristics in patients with chronic CSCR complicated with polypoidal choroidal vasculopathy 1.700
mRNA Level Alterations Of Protein Involved In Cholesterol Ester Metabolism In Pterygium Fibroblast 1.676
null 1.601
Modulation of cholesterol homeostasis by antiproliferative drugs in human pterygium fibroblasts 1.584
Novel P.Asp304gly mutation in best1 gene associated with atypical best vitelliform macular dystrophy phenotype and high intrafamilial variability 1.572
Intravitreal bevacizumab as a treatment for choroidal neovascularisation secondary to myopia: 4-year study results. 1.550
Photodynamic Therapy with Verteporfin for Corneal Neovascularization 1.538
Iatrogenic retinal breaks in ultrahigh-speed 25-gauge vitrectomy: A prospective study of elective cases 1.535
Pterygium and glucose-6-phosphate dehydrogenase deficiency 1.532
Choroidal neovascularization in caucasian patients with longstanding central serous chorioretinopathy 1.529
Influence of macular choroidal thickness on visual function in highly myopic eyes 1.528
Use of a new intra-ocular spectral domain optical coherence tomography in vitreoretinal surgery 1.458
Unilateral retinitis pigmentosa: A proposal of genetic pathogenic mechanisms 1.388
Strategy for the management of diabetic macular edema: the European Vitreo-Retinal Society macular edema study 1.368
Current surgical treatment of age-related macular degeneration 1.357
null 1.350
Terapia Fotodinamica dello Pterigio con Verteporfina 1.334
Engineering erythrocytes for the modulation of drugs' and contrasting agents' pharmacokinetics and biodistribution 1.333
Proliferative Activity and Cholesterol Ester Metabolism in Primary Culture of Human Pterygium Fibroblasts 1.332
Infrared imaging of choroidal involvement in Leber's idiopathic stellate neuroretinitis 1.322
Bilateral noncalcified astrocytic hamartomas in retinitis pigmentosa: Multimodal imaging evaluation over 8 years of follow-up 1.290
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY CHARACTERISTICS OF POLYPOIDAL CHOROIDAL VASCULOPATHY SECONDARY TO CHRONIC CENTRAL SEROUS CHORIORETINOPATHY 1.259
Analysis of Fundus Autofluorescence in Patients with Different Genotypes and Phenotypes of Retinitis Pigmentosa (RP) 1.251
Antiproliferative drugs reduce pterygium fibroblast growth rate by modulating cholesterol homeostasis 1.228
HUMAN AMNIOTIC MEMBRANE TO CLOSE RECURRENT, HIGH MYOPIC MACULAR HOLES IN PATHOLOGIC MYOPIA WITH AXIAL LENGTH OF ≥30 mm 1.217
An international collaborative evaluation of central serous chorioretinopathy: different therapeutic approaches and review of literature. The European Vitreoretinal Society central serous chorioretinopathy study 1.215
Retinal pigment epithelium apertures as a late complication of longstanding serous pigment epithelium detachments in chronic central serous chorioretinopathy 1.214
Correspondence 1.207
Optical coherence tomography angiography findings in cystoid macular degeneration associated with central serous chorioretinopathy 1.207
Optical coherence tomography angiography findings in fellow eyes of choroidal neovascularisation associated with central serous chorioretinopathy 1.190
Vision-Related Quality of Life in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept: The AQUA Study 1.166
Reliable Therapeutic Modalities to Treat Age-Related Macular Degeneration 1.156
Polypoidal choroidal vasculopathy in association with choroidal nevus 1.099
Primary vitreoretinal lymphoma masquerading as acute posterior multifocal placoid pigment epitheliopathy 1.072
Efficacy and safety of combined vitrectomy with intravitreal dexamethasone implant for advanced stage epiretinal membrane 1.071
Observation of Erythrocyte Dynamics in the Retinal Capillaries and Choriocapillaris Using ICG-loaded Erythrocyte Ghost Cells. 1.046
null 1.035
Polypoidal choroidal vasculopathy associated with tilted disc syndrome 1.026
Evaluation of the Choroid in Eyes With Retinitis Pigmentosa and Cystoid Macular Edema 1.025
Anti-vascular endothelial growth factor therapy versus photodynamic therapy in the treatment of choroidal neovascularization secondary to central serous chorioretinopathy 1.011
Negative correlation between retinal displacement and ganglion cell layer thickness changes in eyes with epiretinal membrane 1.009
The nature and frequency of neovascular age-related macular degeneration. 948
Photodynamic therapy of pterygium with verteporfin: a preliminary report 889
Unfavorable effect of photodynamic therapy for late subretinal neovascularization with chorioretinal anastomoses associated with idiopathic multiple serous detachments of the retinal pigment epithelium 871
Discrepancy in current central serous chorioretinopathy classification 866
null 851
Comparison between a fundus camera and scanning laser ophthalmoscope in acquiring fluorescence emission in vitro. 823
Unfavorable effect of photodynamic therapy in a multiple detachment of pigment epithelium complicated by choroidal neovascularization 812
Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease. 808
Amniotic membrane transplantation in the surgical management of symblepharon following toxic epidermal necrolysis 794
Photodynamic therapy of corneal neovascularization with verteporfin 777
Pseudo-vitelliform macular detachment and cuticular drusen: Exclusion of 6 candidate genes 762
Photodynamic therapy in human pterygium. A preliminar report 751
Repopulation of the retinal pigment epithelium after pigment epithelial rip. 694
Diagnosis of Age Related Macular Degeneration. 655
Acute central serous chorioretinopathy and fundus autofluorescence 649
Macular hole formation following thermal laser photocoagulation in a patient with choroidal neovascular membrane and age-related macular degeneration. 637
Erratum: Strategy for the Management of Diabetic Macular Edema: The European Vitreo-Retinal Society Macular Edema Study (BioMed Research International) 633
Photodynamic therapy with Verteporfin (Visudyne) for pterygium 622
Optical Coherence tomography in a case of a double macular hole . 621
null 620
Simultaneous presentation of idiopathic macular and posterior full-thickness retinal holes successfully treated with inverted internal limiting membrane flap technique. 609
Choroidal neovascularization in sorsby fundus dystrophy treated with photodynamic therapy and intravitreal triamcinolone acetonide 590
Hyperexpression of low-density lipoprotein receptors and hydroxy-methylglutaryl-coenzyme A-reductase in human pinguecula and primary Pterygium 570
Cognitive Impairment and Age-Related Vision Disorders: Their Possible Relationship and the Evaluation of the Use of Aspirin and Statins in a 65 Years-and-Over Sardinian Population 549
Late Effect of Irradiation of Choroidal Circulation. 531
Unusual clinical manifestation of sclerochoroidal calcifications. 478
Evolving Treatment Paradigm in the Management of Diabetic Macular Edema in the Era of COVID-19 474
null 472
Choroidal vascularity map in unilateral central serous chorioretinopathy: A comparison with fellow and healthy eyes 467
null 451
null 445
null 424
Short-term choroidal vascular changes after aflibercept therapy for neovascular age-related macular degeneration 417
null 416
En Face Choroidal Vascularity in Both Eyes of Patients with Unilateral Central Serous Chorioretinopathy 408
null 386
Outcomes after giant peripheral retinotomy and anterior flap retinectomy for rhegmatogenous retinal detachments with advanced proliferative vitreoretinopathy using small gauge vitrectomy. 376
null 376
Effect of the First Year of COVID-19 Pandemic on Ophthalmological Practice: A Multi-Centre Italian Study with a Focus on Medico-Legal Aspects 373
Choroidal Anatomic Alterations After Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: A Multicenter Study 368
null 367
Wide-angle viewing lens fogging: solving a common problem in vitreoretinal surgery 366
Oral-ocular trans infection of Epstein Barr virus. A possible new way of transmission by wearing masks in the SARS-CoV-2 era 364
Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial 350
Influence of fellow eye on the diagnosis and classification of central serous chorioretinopathy 339
Analysis of Fundus Autofluorescence in Patients With Different Genotypes and Phenotypes of Retinitis Pigmentosa (RP) 333
INVERTED INTERNAL LIMITING MEMBRANE FLAP TECHNIQUE for MACULAR HOLE SURGERY WITHOUT EXTRA MANIPULATION of the FLAP 312
null 291
Treatments for Ocular Diseases in Pregnancy and Breastfeeding: A Narrative Review. 287
Interocular asymmetry in distribution of leaks in central serous chorioretinopathy 269
Imaging characteristics of bilateral CSCR cases:12 months follow up 262
null 261
Ocular Surface Changes Associated with Face Masks in Healthcare Personnel during COVID-19 Pandemic 242
Totale 98.148
Categoria #
all - tutte 127.291
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.291


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202016.814 0 384 65 257 6.505 4.461 2.571 604 401 463 419 684
2020/202123.602 725 908 874 7.294 5.168 2.563 2.112 1.154 391 896 939 578
2021/20226.036 572 679 269 195 621 444 361 329 463 540 804 759
2022/202311.889 737 1.409 1.079 996 839 1.132 724 1.254 949 811 1.423 536
2023/202412.855 598 405 358 638 1.283 2.000 2.303 825 537 872 1.523 1.513
2024/20257.808 6.135 1.673 0 0 0 0 0 0 0 0 0 0
Totale 101.472